Form 4: Elanco Animal Health Executive Rajeev A. Modi Reports Acquisition of Deferred Stock Units

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units convertible to common stock, according to a Form 4 filing with the SEC.

Summary

• On June 14, 2024, Rajeev A. Modi, an Executive Vice President at Elanco Animal Health Inc., acquired deferred stock units.
• These deferred stock units represent the right to receive one share of Elanco common stock or the cash equivalent.
• A total of 76.7953 deferred stock units were acquired at a price of $18.03.
• Following the transaction, Modi directly owns 1,055.7351 shares of common stock.
• The deferred stock units will settle in cash or shares of common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard executive compensation transaction. It doesn't inherently indicate positive or negative performance for the company.

Positives

• The acquisition of deferred stock units by an executive may signal confidence in the company's future performance.

Future Outlook

The deferred stock units will settle in cash or shares of common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Industry Context

Executive compensation through stock and deferred stock units is a common practice in publicly traded companies to align management's interests with those of shareholders. This filing reflects standard executive compensation practices within the animal health industry.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly listed animal health companies such as Zoetis and IDEXX Laboratories.
• These companies often use stock options, restricted stock units (RSUs), and performance-based equity awards to incentivize executives.
• The specific terms and conditions of these awards, such as vesting schedules and performance metrics, can vary significantly between companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns executive compensation with company performance.

Key Dates